Compounds > erlotinib
Page last updated: 2024-09-05

erlotinib and 4-n-butylresorcinol

erlotinib has been researched along with 4-n-butylresorcinol in 1 studies

Compound Research Comparison

Studies
(erlotinib)		Trials
(erlotinib)		Recent Studies (post-2010)
(erlotinib)		Studies
(4-n-butylresorcinol)		Trials
(4-n-butylresorcinol)		Recent Studies (post-2010) (4-n-butylresorcinol)
221018023719

Protein Interaction Comparison

ProteinTaxonomyerlotinib (IC50)4-n-butylresorcinol (IC50)
Polyphenol oxidase 2Agaricus bisporus0.15

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M1

Other Studies

1 other study(ies) available for erlotinib and 4-n-butylresorcinol

ArticleYear
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
    Disease models & mechanisms, 2023, 03-01, Volume: 16, Issue:3

    Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries

2023